ACTIVE

SYNDESI THERAPEUTICS

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-12 M €+80,3 %over 1 year
Gross margin-6,5 M €+86,9 %over 1 year
Equity-129,9 M €-10,1 %over 1 year

Identity

Source · BCE/KBO

SYNDESI THERAPEUTICS is a Public limited company incorporated in 2017. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Wavre.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0686.599.355
Incorporation
19/12/2017
Legal form
Public limited company
Registered office
Avenue Einstein 14
1300 Wavre · WallonieSee on map
Contributed capital
29 296 275,18 €
Latest accounts
31/12/2025
Joint committees (1)
  • 207
Contacts
2 public details availableLog in to view

Financials

Source · NBB, 9 filings

Trend over 7 financial years

20252024202320212020
Income statement
Gross margin-6,5 M €-49,5 M €-47 M €-5,2 M €-6,1 M €
EBITDA-6,5 M €-49,5 M €-47 M €-5,5 M €-6,4 M €
Operating result-6,5 M €-49,5 M €-47 M €-6,5 M €-7,3 M €
Net result-12 M €-60,6 M €-46,6 M €-6,3 M €-7,1 M €
Balance sheet
Equity-129,9 M €-118 M €-57,4 M €6,2 M €6,5 M €
Total assets607,5 k €1,6 M €684,7 k €8,2 M €8,2 M €
Cash–––6,5 M €5,7 M €
Debts116,4 M €119,6 M €58,1 M €2 M €1,7 M €

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 25 ended

Active mandates

Erica Silbiger

Director · since 01 avril 2026 · until 29 mai 2028

Active
Rolfe van de Spreng

Director · since 01 décembre 2025 · until 31 mars 2026

Active
Jean Antoine de Los Frailes

Director · since 25 février 2022 · until 30 novembre 2025

Active
Renaud Decroix

Director · since 25 février 2022 · until 29 mai 2028

Active

Ended mandates

Scott Reents

Director · since 01 décembre 2022 · until 21 novembre 2024

Ended
Scott Reents

Director · since 01 décembre 2022

Ended
Jean Antoine de Los Frailes

Director · since 25 février 2022 · until 29 mai 2028

Ended
Robert Michael

Director · since 25 février 2022 · until 29 mai 2028

Ended

Other companies at this address

Avenue Einstein 14 1300 Wavre
CompanyCBE no.
ABBOTT● Active
0403.044.007
ABBVIE● Active
0845.096.860

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date08/06/202617/06/202522/07/202412/10/202325/07/202210/06/2021
General meeting26/05/202602/06/202528/06/202403/10/202330/06/202231/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 9 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202526/05/202608/06/2026FrenchPDF
Abridged model31/12/202402/06/202517/06/2025FrenchPDF
Micro model31/12/202328/06/202422/07/2024FrenchPDF
Micro model31/12/202203/10/202312/10/2023FrenchPDF
Micro model31/12/202130/06/202225/07/2022FrenchPDF
Micro model31/12/202031/05/202110/06/2021FrenchPDF
Micro model31/12/201925/05/202026/06/2020FrenchPDF
Micro modelCorrection31/12/201827/05/202026/06/2020FrenchPDF
Micro model31/12/201827/05/201928/05/2019FrenchPDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 25 ended

Active mandates

Erica Silbiger

Director · since 01 avril 2026 · until 29 mai 2028

Active
Rolfe van de Spreng

Director · since 01 décembre 2025 · until 31 mars 2026

Active
Jean Antoine de Los Frailes

Director · since 25 février 2022 · until 30 novembre 2025

Active
Renaud Decroix

Director · since 25 février 2022 · until 29 mai 2028

Active

Ended mandates

Scott Reents

Director · since 01 décembre 2022 · until 21 novembre 2024

Ended
Scott Reents

Director · since 01 décembre 2022

Ended
Jean Antoine de Los Frailes

Director · since 25 février 2022 · until 29 mai 2028

Ended
Robert Michael

Director · since 25 février 2022 · until 29 mai 2028

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates07/05/2026
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates06/01/2026
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates23/12/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates14/11/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Registered office05/12/2023
    SIEGE SOCIAL - ADRESSE AUTRE QUE SIEGE SOCIAL
    PDF
  • Mandates03/01/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates17/03/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates10/03/2022
    DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-12 M €↑
  2. 2024
    Annual accounts 2024-60,6 M €↓
  3. 2023
    Annual accounts 2023-46,6 M €↓
  4. 2021
    Annual accounts 2021-6,3 M €↑
  5. 2020
    Annual accounts 2020-7,1 M €↓
  6. 2019
    Annual accounts 2019-3,7 M €↓
  7. 2018
    Annual accounts 2018-3,5 M €
  8. 19/12/2017
    IncorporationPublic limited company